TechCrunch’s Matthew Panzarino has an interesting look at Project Tango, the 3D-sensing prototype phone that Google announced on Thursday: Most 3D-sensing platforms — like the PrimeSense chip inside ...
TNG260 is a first-in-class, highly selective CoREST complex inhibitor currently being evaluated with pembrolizumab in the dose expansion phase of the TNG260 Phase 1/2 trial. The trial is currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback